MedTrace Logo

Magnesphere for Autonomic Alteration

NCT04207476 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2026-01-26

No results posted yet for this study

Summary

To evaluate the physiologic effects of an electromagnetic resonator(EMF) on autonomic nervous system tone modulation through measurement of heart rate variability(HRV).

Null Hypothesis: An EMF Resonator will not change autonomic nervous system tone and no demonstrable difference in physiological parameters will recorded.

Alternative Hypothesis: Using an EMF Resonator will enhance parasympathetic activty as supported by HRV.

Conditions

  • Hart Failure With Reduced Ejection Fraction

Interventions

DEVICE

EMF

Active magnetic field exposure will be performed by use of a EMF resonator. Stimulator will be applied continuously for 1 hour.

DEVICE

Placebo

No magnetic field exposure will be given while patients are assigned to this arm for a duration of 1 hour.

Sponsors & Collaborators

  • University of Oklahoma

    lead OTHER

Principal Investigators

  • Tarun Dasari, MD · OUHSC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-25
Primary Completion
2022-10-12
Completion
2022-10-12
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04207476 on ClinicalTrials.gov